secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001493152-23-038400
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $40K convertible note to 1800 Diagonal Lending
-----------------------------------------------------------------------

- Principal $40,000, convertible at 65% of lowest three trading prices in prior ten trading days.
- Interest 8% per annum (22% on default); maturity October 20, 2024.
- Company may prepay at 110%-129% premium within first 180 days; no prepayment after that.
- Proceeds used for general working capital; funds not yet received as of filing date.
- Conversion subject to 4.99% beneficial ownership limitation; 500% initial share reserve required.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223038400/0001493152-23-038400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223038400/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-038400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer